Sanofi | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
AbbVie USD 3.32B 2.71B 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Galapagos EUR 2.9B 34.37M 2024-12
Genmab DKK 36.7B 4.78B 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Indivior -167000000 46M 2024-09
J&J USD 71.49B 1.33B 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Prestige Brands USD 1.79B 56.67M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
Sanofi 77.86B 4.86B 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
UCB EUR 10.03B 1.08B 2024-12
Zoetis USD 4.77B 464M 2024-12



Sanofi Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.